SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-441095
Filing Date
2013-11-14
Accepted
2013-11-14 07:00:49
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d602010d10q.htm 10-Q 505098
2 EX-31.1 d602010dex311.htm EX-31.1 7038
3 EX-31.2 d602010dex312.htm EX-31.2 7055
4 EX-32.1 d602010dex321.htm EX-32.1 3947
5 EX-32.2 d602010dex322.htm EX-32.2 3965
  Complete submission text file 0001193125-13-441095.txt   3248779

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT idra-20130930.xml EX-101.INS 326344
7 XBRL TAXONOMY EXTENSION SCHEMA idra-20130930.xsd EX-101.SCH 51556
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE idra-20130930_cal.xml EX-101.CAL 39721
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE idra-20130930_def.xml EX-101.DEF 142803
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE idra-20130930_lab.xml EX-101.LAB 307257
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idra-20130930_pre.xml EX-101.PRE 205359
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 131216730
SIC: 2836 Biological Products, (No Diagnostic Substances)